LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 210 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,063 | +2.4% | 17,769 | +23.4% | 0.00% | 0.0% |
| Q2 2023 | $1,038 | -4.5% | 14,403 | -2.5% | 0.00% | – |
| Q1 2023 | $1,087 | -56.4% | 14,768 | -60.4% | 0.00% | -100.0% |
| Q4 2022 | $2,492 | -99.9% | 37,323 | +34.4% | 0.00% | -66.7% |
| Q3 2022 | $2,392,000 | +376.5% | 27,773 | +393.7% | 0.00% | – |
| Q2 2022 | $502,000 | -77.8% | 5,626 | -72.0% | 0.00% | -100.0% |
| Q1 2022 | $2,263,000 | -87.1% | 20,115 | -82.3% | 0.00% | -33.3% |
| Q4 2021 | $17,564,000 | +182.2% | 113,708 | +154.5% | 0.00% | 0.0% |
| Q3 2021 | $6,224,000 | +51.0% | 44,678 | +42.2% | 0.00% | +50.0% |
| Q2 2021 | $4,121,000 | -32.8% | 31,419 | -21.9% | 0.00% | -33.3% |
| Q1 2021 | $6,137,000 | +114.5% | 40,249 | +39.9% | 0.00% | +50.0% |
| Q4 2020 | $2,861,000 | -36.6% | 28,761 | -39.3% | 0.00% | -33.3% |
| Q3 2020 | $4,514,000 | -42.6% | 47,355 | -32.6% | 0.00% | -50.0% |
| Q2 2020 | $7,863,000 | +53.8% | 70,294 | -0.0% | 0.01% | +50.0% |
| Q1 2020 | $5,113,000 | -46.4% | 70,304 | -23.1% | 0.00% | -20.0% |
| Q4 2019 | $9,533,000 | +24.6% | 91,420 | +18.9% | 0.01% | 0.0% |
| Q3 2019 | $7,652,000 | -29.7% | 76,874 | -19.4% | 0.01% | -16.7% |
| Q2 2019 | $10,881,000 | +1.5% | 95,321 | +11.8% | 0.01% | -14.3% |
| Q1 2019 | $10,721,000 | +16.4% | 85,284 | +25.7% | 0.01% | 0.0% |
| Q4 2018 | $9,209,000 | -76.8% | 67,860 | -53.1% | 0.01% | -75.0% |
| Q3 2018 | $39,719,000 | +28.1% | 144,697 | -3.3% | 0.03% | +3.7% |
| Q2 2018 | $30,996,000 | +624.9% | 149,611 | +478.0% | 0.03% | +800.0% |
| Q1 2018 | $4,276,000 | +627.2% | 25,884 | +502.8% | 0.00% | – |
| Q4 2017 | $588,000 | +335.6% | 4,294 | +334.6% | 0.00% | – |
| Q3 2017 | $135,000 | -77.4% | 988 | -79.9% | 0.00% | -100.0% |
| Q2 2017 | $598,000 | -90.3% | 4,927 | -91.5% | 0.00% | -85.7% |
| Q1 2017 | $6,156,000 | +6.0% | 58,164 | +1.8% | 0.01% | +16.7% |
| Q4 2016 | $5,805,000 | +0.2% | 57,130 | +0.7% | 0.01% | -14.3% |
| Q3 2016 | $5,792,000 | +12223.4% | 56,761 | +14161.6% | 0.01% | – |
| Q2 2016 | $47,000 | -95.2% | 398 | -95.6% | 0.00% | -100.0% |
| Q1 2016 | $971,000 | +716.0% | 9,070 | +719.3% | 0.00% | – |
| Q4 2015 | $119,000 | -76.5% | 1,107 | -81.5% | 0.00% | -100.0% |
| Q3 2015 | $507,000 | +457.1% | 5,970 | +555.3% | 0.00% | – |
| Q2 2015 | $91,000 | -67.5% | 911 | -75.1% | 0.00% | – |
| Q1 2015 | $280,000 | +147.8% | 3,659 | +73.3% | 0.00% | – |
| Q4 2014 | $113,000 | -93.0% | 2,111 | -94.0% | 0.00% | -100.0% |
| Q3 2014 | $1,610,000 | +648.8% | 35,009 | +907.5% | 0.00% | – |
| Q2 2014 | $215,000 | -98.9% | 3,475 | -98.8% | 0.00% | -100.0% |
| Q1 2014 | $19,856,000 | +213.8% | 296,358 | +143.5% | 0.02% | +266.7% |
| Q4 2013 | $6,328,000 | +891.8% | 121,683 | +720.3% | 0.01% | +500.0% |
| Q3 2013 | $638,000 | +625.0% | 14,834 | +529.9% | 0.00% | – |
| Q2 2013 | $88,000 | – | 2,355 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |